Skip to main content

Publications

24 publications

Funding

5 grants

Active

2 grants
  • PI
    Modular Switchable mRNAs for Tissue and Cell-Specific mRNA-based Therapies
    Qatar National Research Fund · 2024–2027
    ARG01-0605-230503
  • PI
    An RNA-based therapy for the treatment of familial hypercholesterolemia and atherosclerosis
    Qatar National Research Fund · 2023–2025
    NPRP14S-0401-210126
Completed grants (3)
  • Sub-PI
    Evaluation of a myeloid microRNA in atherosclerosis
    Weill Cornell Medical College/Qatar · 2022–2025 · via Leiden University Medical CenterContract
    225267-01
  • PI
    Najafi -- MODERNA SRA
    ModernaTX · 2019–2020Contract
    SRA 193564-01
  • PI
    miR-33b in Pancreatic -Cell Dysfunction and Lipotoxicity
    Qatar Foundation · 2016–2019
    NPRP8-346-1-072

Available technologies

News mentions

  • The Power of Partnership in Innovation
    April 14, 2025

    Nearly 200 scientists, investors and industry representatives attended Weill Cornell Medicine’s 2025 Biomedical Innovation Conference April 1, sharing their startup journeys and experiences nurturing biomedical advances into health care products and companies.

  • Scientists Pitch Medical Innovations at 2023 Biomedical Business Plan Challenge
    June 16, 2023

    Six teams pitched their innovations at the 2023 Biomedical Business Plan Challenge Final Pitch Day competition for $100,000 in prize money, which can be used to help build their company, with the goal of ushering in the next generation of life science innovation and patient care.

Mentoring

1 mentee